Nurmohamed M, Choy E, Charles-Schoeman C, et al. Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials. ACR 2017, abstract 2966.
Ongelijke behandeling in de spreekkamer? Ja, graag!
dec 2018